Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4 small nuclear 82, pseudogene (RNU4-82P) is a predicted pseudogene listed in genome databases[1]. It is annotated as a non-coding RNA by sequence homology to functional U4 small nuclear RNAs, but is currently considered non-functional and has not been shown to produce an active RNA product or protein, nor to participate in biological pathways or disease associations[1]. As a pseudogene, RNU4-82P is not regarded as a receptor, enzyme, transporter, or any other conventional therapeutic target class. There may be confusion with RNU4-2 (RNA, U4 small nuclear 2), which is a functional small nuclear RNA in the spliceosome and has a strong, well-established role in splicing and is associated with syndromic neurodevelopmental disorder when mutated[3][4][5][6][7]. However, RNU4-82P is a different locus, annotated as a pseudogene, not a functional gene[1]. No pathway, disease, or drug interaction information is available for RNU4-82P; all recent disease/biological relevance in the search results pertains to RNU4-2, not RNU4-82P[1][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 82, pseudogene (RNU4-82P).